This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Antitrust litigation - In re Generic pharmaceuticals pricing antitrust litigation

Generic pharmaceutical companies are being sued over alleged price-fixing of a number of drugs.

For more on the digoxin and doxycycline litigation, see here.
For more on the Lidocaine/Prilocaine litigation, see here
For more on the Glyburide litigation, see here
For more on the Ursodiol litigation, see here.
For more on the Clomipramine litigation, see here
For more on the Econazole litigation, see here
For more on the Propranolol litigation, see here
For more on the Clobetasol Propionate litigation, see here
For more on the Levothyroxine litigation, see here
For more on the Divalproex ER litigation, see here
For more on the Pravastatin litigation, see here
For more on the Desonide litigation, see here
For more on the Lidex litigation, see here
For more on the fluocinonide litigation, see here
For more on the Amitriptyline litigation, see here
For more on the benazepril and hydrochlorothiazide litigation, see here.

Timeline

Parties

Get the inside track, with MLex

With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.


  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

TRY MLEX FREE FOR 14 DAYS